Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

7.435 -0.065 (-0.87%)
Streaming Delayed Price Updated: 12:17 PM EDT, Aug 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
64 65 Next >
Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025
These beaten-down innovators have industry-changing potential. 
Via The Motley Fool
What Is Going on With Novavax (NVAX) Stock Today?
Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19. 
Via InvestorPlace
Canada Approves Novavax's COVID-19 Vaccine As Booster In Adults
Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older. 
Via Benzinga
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
Could This Bullish News Make Novavax a Hot Buy?
Can this turn the stock's fortunes around? 
Via The Motley Fool
Is It Too Late to Buy Novavax Stock?
The company has been struggling lately. 
Via The Motley Fool
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler... 
Via Benzinga
2 Cheap Stocks to Buy Right Now
Both companies performed well during the worst of the pandemic, but things have changed since then. 
Via The Motley Fool
Here Are All 23 Stocks I've Bought During the 2022 Bear Market
A historically bad year for Wall Street is a gift for long-term investors with cash at the ready. 
Via The Motley Fool
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
 
Via Benzinga
Nasdaq Bear Market: 3 Phenomenal Bargains That Can Double Your Money by 2027
These amazing deals are ripe for the picking and poised to deliver triple-digit returns in five years. 
Via The Motley Fool
Novavax Posts Unexpected Q3 Loss, But Revenue Surpass Expectations
Novavax Inc (NASDAQ: NVAX) revised its FY22 sales forecast for the second time in three months amid waning demand for COVID-19 vaccines. 
Via Benzinga
The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter Earnings
Investors are looking for one key positive metric from Novavax's third-quarter earnings. 
Via Investor's Business Daily
Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses
 
Via Benzinga
Preview: Novavax's Earnings
Novavax (NASDAQ:NVAX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Novavax will report... 
Via Benzinga
7 Nasdaq Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole
With macro forces changing the paradigm in the equities sector and the broader economy, it’s time to consider Nasdaq stocks to avoid. 
Via InvestorPlace
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends. 
Via InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Avis Budget, Scholastic And Other Big Gainers From Monday
U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Moderna, Amazon, Tesla, And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. 
Via Benzinga
Why Novavax Stock Rose 12.57% on Friday
Investors did an about-face after the stock slumped earlier in the week. 
Via The Motley Fool
Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today?
Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit? 
Via InvestorPlace
Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets. 
Via Benzinga
Twitter Rebuffs Elon Musk Layoff Plans Report, Toyota Cuts 2023's Production Target, Vaccine Makers Expect 3x Price Increase In COVID-19 Shot: Top Stories Friday, Oct. 21
Bloomberg 
Via Benzinga
Jim Cramer Says This Stock 'Down Here At This Level Is A Terrific Buy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is against Novavax (NASDAQ: NVAX). 
Via Benzinga
Vaccine Makers Mull Price Increase For COVID-19 Boosters Amid Falling Demand
 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Why Moderna Stock Dropped Today
Competition is intensifying. 
Via The Motley Fool
Why Novavax Stock Couldn't Win on Wednesday
FDA authorization isn't necessarily a slam dunk for a company. 
Via The Motley Fool
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.